0
RECOMMENDED FOR NEW DESIGNS
The ADAS1021 is a highly integrated, analog front end (AFE) designed for measurement of patient biopotential information. The primary measurement performed is electrocardiogram (ECG) activity, where the ADAS1021 employs dedicated Σ-Δ analog-to-digital converters (ADCs) per channel to acquire and digitize on a lead basis. The signal acquisition is architected to support low noise, diagnostic level measurement in the presence of a variety of interferers.
The ADAS1021 also includes three dedicated successive approximation register (SAR) ADCs to digitize the high frequency pacemaker content that is analyzed by the on-chip pacemaker detection algorithm.
A dedicated and flexible impedance measurement block captures impedance variation during patient respiration and is available on multiple leads.
The ADAS1021 has a number of complementary features supporting ECG measurement: driven reference for common-mode rejection and lead-off detection that identifies if an electrode connection is degrading or has fallen off. The product also includes a shield drive amplifier to bias the shield of the cable.
Applications